TABLE 2.
Routine considerations when assessing laboratory risk, WCLN risk assessment survey respondents, 2016a
Consideration | % of respondents |
---|---|
Specimen source and associated pathogens | 100.0 |
Test requisitionb | 98.1 |
Method of transmission and infectious dose | 84.5 |
Risk factors for persons performing testingc | 81.6 |
Patient symptoms and travel history | 51.5 |
Patient occupation | 24.3 |
Data are for 103 respondents.
Including, but not limited to, tests for systemic mycotic agents, acid-fast bacilli, viruses, and potential bioterrorism agents.
Including, but not limited to, immunization status, pregnancy, illness or treatment, physical disability, and training and experience.